Moreover, Tiam1 and Rac1 were overexpressed in a 3-D model of lymphoma, where treatment with Tiam1/Rac1 inhibitor NSC23766 overcame chemoresistance to doxorubicin (Ikram et al., 2018). The gene discussed is RAC1; the disease is lymphoma.